1 / 5

Radiopharmaceuticals/Nuclear Medicine Market Size, Share & Growth 2029

The global Radiopharmaceuticals/Nuclear Medicine Market was valued at US$ 5605 Million in 2022 and is anticipated to grow at US$ 9327 Million by 2029 recording a CAGR of 9.3% during the forecast period 2023-2029

MathurReshma
Download Presentation

Radiopharmaceuticals/Nuclear Medicine Market Size, Share & Growth 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Radiopharmaceuticals/Nuclear Medicine Market (2023-2029)

  2. Market Overview: The global Radiopharmaceuticals/Nuclear Medicine Market was valued at US$ 5605 Million in 2022 and is anticipated to grow at US$ 9327 Million by 2029 recording a CAGR of 9.3% during the forecast period 2023-2029. The Radiopharmaceuticals/Nuclear Medicine Market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of theRadiopharmaceuticals/Nuclear Medicine Market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description

  3. Market Segments: • The Radiopharmaceuticals/Nuclear Medicine Market has been fragmented based on: • By Product Type: Diagnostic Radiopharmaceuticals (SPECT Radiopharmaceuticals and PET Radiopharmaceuticals) and Therapeutic Radiopharmaceuticals (Beta Emitters, Alpha emitters, Brachytherapy, and Others) • By Application: oncology, neurological disorders, cardiovascular disease, thyroid, and Others • By Route of Administration: oral, inhalation, and Parenteral • By End User: Hospitals, Clinics, Diagnostic Centers, and Research Institutes • Request Sample Report

  4. Key Players: • Some of the major key players in the Radiopharmaceuticals/Nuclear Medicine Marketare: • Advanced Accelerator Applications • Bayer • Bracco Imaging • Cardinal Health • Eli Lilly and Co. • GE Healthcare • IBA Molecular Imaging • Jubilant Life Sciences Ltd • Lantheus Medical Imaging • Request Sample Report

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553

More Related